bds-web-hero-10710-2000x568

Single-Use Technologies for Bulk Drug Substance Freeze/Ship/Thaw Process Based on Bags webinar. (previously recorded)


Register to View Recorded Webinar

New biopharmaceutical drug products that alter and even save lives can be very profitable for their developers. They are, however, costly to develop and represent significant investment, particularly at the end of the manufacturing process. For this reason, safe cost-effective frozen storage and transport are critical, especially as drugs transition from R&D through clinical trial and to higher volume production.

In this recorded webinar, Mike Johnson, Entegris Director R&D Engineering, and Johannes Kirchmair, CEO/Founder of Single Use Support (SUS), present single-use bag system technologies for freeze/thaw applications in bulk drug substance (BDS) manufacturing.

Transitioning to more efficient, cost-effective, single-use solutions that can help biopharmaceutical manufacturers hit performance targets at high yields.

Learn more.  

10710_SUS support graphic

Presenters

  • Mike Johnson 
    Director R&D Engineering
    Entegris. Inc.

  • Johannes Kirchmair Read Bio
    CEO/Founder
    Single Use Support GmbH

For more information on Cold Chain Bioprocessing.

Read the bios on our speakers, visit our event page